Mj. Patel et al., SECRETION OF CYCLIC-GMP BY CULTURED EPITHELIAL AND FIBROBLAST CELL-LINES IN RESPONSE TO NITRIC-OXIDE, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 16-25
LLC-PK1 epithelial cells and RFL-6 fibroblasts secreted both cyclic AM
P (cAMP) and cyclic GMP (cGMP) when costimulated with forskolin and 3-
morpholinosydnonimine (a chemical nitric oxide generator). Intracellul
ar cAMP levels as high as 1100 and 12,000 pmol/10(6) cells were achiev
ed for the two cell types, respectively. These levels were high enough
to reach approximately 50% saturation of the cAMP transporter and inh
ibited transport of cGMP to an equal extent, suggesting that the two c
yclic nucleotides compete for a common transport system. The rates of
secretion of cGMP and cAMP from LLC-PK1 cells increased in proportion
to their rates of synthesis as concentrations of stimulant were varied
, but increased only 25% relative to intracellular concentrations in r
esponse to inhibition of phosphodiesterases by 3-isobutylmethylxanthin
e. It is proposed that secretion of cyclic nucleotides is not simply p
roportional to the total intracellular pool in these cells, but rather
is coupled to synthesis. In support of this model, oxyhemoglobin was
used to trap nitric oxide and block activity of guanylate cyclase in c
ells treated with 3-morpholinosydnonimine. As a result, secretion of c
GMP ceased within 1 min, whereas intracellular levels decreased slowly
over 60 min. Probenecid [p-(dipropylsulfamoyl)benzoic acid] is a nons
elective antagonist of anion transport that inhibited secretion of cAM
P in both cell types but, unexpectedly, blocked synthesis of cGMP, and
this was reflected in direct inhibition of soluble guanylate cyclase
in cell lysates. Two heat-stable, high molecular weight factors that c
onfer sensitivity to probenecid were identified, and these factors inc
reased the sensitivity of guanylate cyclase to nitric acid by an order
of magnitude.